These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of direct pharmacist intervention on conversion from parenteral to oral histamine H2-receptor antagonist therapy. Kirking DM; Svinte MK; Berardi RR; Cornish LA; Chaffee BW; Ryan ML DICP; 1991 Jan; 25(1):80-4. PubMed ID: 1672572 [TBL] [Abstract][Full Text] [Related]
3. Role of histamine (H2)-receptor antagonists in total parenteral nutrition patients. Baptista RJ Am J Med; 1987 Dec; 83(6A):53-7. PubMed ID: 2892408 [TBL] [Abstract][Full Text] [Related]
4. Evolving perspectives on parenteral H2-receptor antagonist therapy. Peura DA; Freston JW Am J Med; 1987 Dec; 83(6A):1-2. PubMed ID: 2892403 [No Abstract] [Full Text] [Related]
5. Considerations for selection of parenteral histamine (H2)-receptor antagonists. Wolfe MM Am J Med; 1987 Dec; 83(6A):82-8. PubMed ID: 2892411 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of gastric secretion in man with a new H2-receptor antagonist, ranitidine. Kett K; Aadland E; Berstad A Scand J Gastroenterol; 1980; 15(2):249-51. PubMed ID: 6104355 [TBL] [Abstract][Full Text] [Related]
7. Indications for the use of parenteral H2-receptor antagonists. Thompson JC; Walker JP Am J Med; 1984 Nov; 77(5B):111-5. PubMed ID: 6150638 [TBL] [Abstract][Full Text] [Related]
8. A critical review of continuous infusion H2 receptor therapy. Rovers JP; Souney PF Crit Care Med; 1989 Aug; 17(8):814-21. PubMed ID: 2568898 [TBL] [Abstract][Full Text] [Related]